News | June 25, 2009

CAD Detects Cancers on CR Mammography that Go Unnoticed

June 25, 2009 – “Our research confirmed that by adding computer-aided detection, readers are better equipped to detect breast cancers that otherwise would not be identified,” said Rachel F. Brem, M.D., professor of Radiology, and vice chair of Research and Faculty Development at The George Washington University Medical Center, at the Computer Assisted Radiology and Surgery (CARS) 23rd International Congress and Exhibition being held in Berlin, Germany from June 23-27 2009.

The multicenter study evaluated the performance of computer-aided detection (CAD) with computed radiography (CR) for mammography in the detection of breast cancers that had previously been missed, using iCAD’s SecondLook Digital.

Dr. Brem’s findings showed that of the confirmed cancers, 55 percent were missed by at least one of the six readers. CAD correctly pinpointed 88 percent of all cancers, adding further evidence of the clinical need for CAD with CR.

“Even under ideal circumstances, it can be difficult for radiologists to determine what abnormalities in a mammogram could be cancerous and warrant closer evaluation,” said Dr. Brem.

In addition, special sessions on breast CAD including real-time demonstrations, panel discussions and clinical evaluations of iCAD’s technology were shared at CARS.

Original research presented by Dr. Brem further supported the use of computer-aided detection as an effective breast cancer detection tool. Dr. Brem is a member of iCAD Inc.’s board of directors.

For more information: www.icadmed.com

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...